Supraventricular tachycardia AHA recommendations for Management of IST: Difference between revisions
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{AA}} | {{CMG}} {{AE}}{{AA}} | ||
==Overview== | ==Overview== | ||
Evaluation for and treatment of reversible causes are recommended in patients with suspected IST. | Evaluation for and treatment of reversible causes are recommended in patients with suspected IST. Ivabradine is reasonable for ongoing management in patients with symptomatic IST. | ||
==Management of IST(Inappropriate sinus tachycardia)== | ==Management of IST(Inappropriate sinus tachycardia)== | ||
Revision as of 15:39, 27 October 2016
|
Supraventricular tachycardia Microchapters |
|
Differentiating Among the Different Types of Supraventricular Tachycardia |
|---|
|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
|
Diagnosis |
|
Treatment |
|
2015 ACC/AHA Guideline Recommendations |
|
Case Studies |
|
Supraventricular tachycardia AHA recommendations for Management of IST On the Web |
|
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of IST |
|
FDA on Supraventricular tachycardia AHA recommendations for Management of IST |
|
CDC on Supraventricular tachycardia AHA recommendations for Management of IST |
|
Supraventricular tachycardia AHA recommendations for Management of IST in the news |
|
Blogs on Supraventricular tachycardia AHA recommendations for Management of IST |
|
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Evaluation for and treatment of reversible causes are recommended in patients with suspected IST. Ivabradine is reasonable for ongoing management in patients with symptomatic IST.
Management of IST(Inappropriate sinus tachycardia)
2015 AHA recommendations for management of IST are described below:[1]
Acute treatment of IST (Inappropriate sinus tachycardia)
There are no specific recommendations for acute treatment of IST.
Treatment of ongoing IST
| Class I |
| "1.Evaluation for and treatment of reversible causes are recommended in patients with suspected IST "(Level of Evidence: C-LD) " |
| Class IIa |
| "1.Ivabradine is reasonable for ongoing management in patients with symptomatic IST "(Level of Evidence: B-R) " |
| Class IIb |
| "1.Beta blockers may be considered for ongoing management in patients with symptomatic IST "(Level of Evidence:C-LD) " |
| "2.The combination of beta blockers and ivabradine may be considered for ongoing management in patients with IST ( "(Level of Evidence: C-LD) " |
References
- ↑ Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ; et al. (2016). "2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". J Am Coll Cardiol. 67 (13): e27–e115. doi:10.1016/j.jacc.2015.08.856. PMID 26409259.